 MINNEAPOLIS--BUSINESS WIRE--DiaMedica Therapeutics Inc. Nasdaq: DMAC, a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that Rick Pauls, its President and CEO will be participating at Lake Street Capital Markets 6th Annual Best Ideas Growth BIG6 Conference in New York, on September 14, 2022. Management will conduct one-on-one meetings with investors during the conference. To receive additional 